Filters

Showing all 7 results

Please add widgets to the WooCommerce Filters widget area in Appearance > Widgets

7 products

  • SARS-CoV-2 Rapid Antigen Test (Colloidal Gold Method)

    BRIEF

    The SARS-CoV-2 Rapid Antigen Test (Colloidal Gold Method) is intended for the qualitative detection of the SARS-CoV-2 nucleocapsid protein in human nasopharyngeal or nasal swab sampled from individuals suspected of COVID-19.

    PARAMETER

    • Testing time: 10-15 minutes
    • Sensitivity: 98.4%
    • Specificity: 98.1%

    KIT COMPONENTS

    No. Product Name Spec.
    S3109E-25 SARS-CoV-2 Rapid Antigen Test (Colloidal Gold Method) 25 tests
  • SARS-CoV-2 Rapid Antigen Test (Immunochromatography Assay)

    BRIEF

    The SARS-CoV-2 Rapid Antigen Test (Immunochromatography Assay) adopts latex immunochromatography technology and utilizes double-antibody-sandwich method to qualitatively detect SARS-CoV-2 antigen in human nasal, nasopharyngeal or oropharyngeal swab sampled.

    PRODUCT FEATURES

    INSTRUCTION

    RESULT INTERPRETATION

    KIT COMPONENTS

    No. Product Name Spec.
    S3120E-25 SARS-CoV-2 Rapid Antigen Test (Immunochromatography Assay) 25 tests
    The kit components:
    • SARS-CoV-2-Antigen Test Cassette
    • SARS-CoV2 Sample Extraction Buffer
    • Dripper
    • Extraction Tube
    • Disposable Sampler
  • SARS-CoV-2 Mutation Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing)

    BRIEF

    The SARS-CoV-2 Mutation Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) is used to identify whether the virus contains mutation sites N501Y and HV 69-70del in nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluids, saliva and sputum from patients who have been diagnosed with SARS-CoV-2 infection.

    PERFORMANCE

    • ARMS-PCR: Accurate detection of N501Y, HV 69-70delmutation sites
    • Ultra fast: Optimize testing procedures, amplification time only 60min
    • High sensitivity: Detection sensitivity reaches 200 copies/mL
    • Internal control: Rnase P, Monitor the whole process (Sampling, Extraction and Amplification )

    PARAMETERS

    Product features Parameters
    Specimen Type Nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, saliva and sputum
    Extraction Platform One-tube fast release technology / Advanced magnetic beads technology
    Target Genes N501Y, HV 69-70del, N gene
    Internal Control Rnase P gene
    PCR Instrument SLAN-96P, ABI7500, QuantStudio 5
    Sensitivity 200copies/mL
    Spec. 24T/48T
  • Detection Kit for 5 Mutations of SARS-CoV-2

    BRIEF

    Detection Kit for 5 Mutations of SARS-CoV-2, detects 5 SARS-CoV-2 variants, including E484K, K417N, P681H, N501Y and HV 69-70del, which covers Most Worrying Mutations.

    PERFORMANCE

    • MORE COMPREHENSIVE: Accurate detection of 5 mutation sites
    • Ultra fast: Optimize testing procedures, amplification time only 60min
    • High sensitivity: Detection sensitivity reaches 200 copies/mL
    • Internal control: Rnase P, Monitor the whole process

    PARAMETERS

    Product features Parameters
    Specimen Type Oropharyngeal swab, sputum, alveolar lavage fluid, nasopharyngeal swab and saliva
    Extraction Platform Advanced magnetic beads technology
    Target Genes E484K, K417N, P681H, N501Y, HV 69-70del, N gene
    Internal Control Rnase P
    PCR Instrument SLAN-96P, ABI7500, QuantStudio 5
    Sensitivity 200copies/mL
    Spec. 24T/48T
  • SARS-CoV-2 and Influenza A/B Virus Nucleic Acid Diagnostic Kit (Multiplex PCR-Fluorescence Probing)

    BRIEF

    Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Elder people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. Sansure COVID-19 diagnostic solutions are used to directly detect  the presence of viral RNA, which will be detectable in patients before antibodies form or symptoms of the disease are present, which means the test results can tell whether or not that someone gets virus very early on in their illness. This kit can also joint-detect RNA of influenza A virus and influenza B virus.

    PARAMETERS

    Product features Parameters
    Specimen Type Oropharyngeal swab, sputum
    Extraction Platform One-tube fast release technology / Advanced magnetic beads technology
    Target Genes SARS-CoV-2:ORF 1ab, N gene;influenza A:M gene;influenza B:NP gene
    Internal Control Rnase P gene
    PCR Instrument SLAN-96P, Portable Molecule Workstation (S-Q31A、S-Q31B).
    Sensitivity 200copies/mL
    Spec. 24T/48T
  • SARS-CoV-2 Multiplex Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing)

    BRIEF

    COVID-19 is an infectious disease caused by a newly discovered coronavirus named SARS-CoV2. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Elder people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. The SARS-CoV-2 Multiplex Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) is used for qualitative detection of the ORF1ab,N and E genes of SARS-CoV-2 in nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, saliva and sputum from patients with SARS-CoV-2 infection, suspected cases with SARS-CoV-2 infection and other patients requiring diagnosis or differential diagnosis of SARS-CoV-2 infection.

    PERFORMANCE

    • Performance upgrade: ORF 1ab, N, E genes, three targets
    • High sensitivity: 200copies/ml (One-tube fast release technology), 50 copies/ml (advanced magnetic beads method)
    • Time saving: the amplification time was 60min, and the extraction time was the shortest 30min

    PARAMETERS

    Product features Parameters
    Specimen Type Nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, saliva and sputum
    Extraction Platform One-tube fast release technology / Advanced magnetic beads technology
    Target Genes ORF 1ab, N, E gene
    Internal Control Pseudovirus containing internal control gene fragments
    PCR Instrument SLAN-96P, ABI7500, QuantStudio 5, S-Q31A, S-Q31B
    Sensitivity 200copies/mL(Sample Release Reagent ); 50copies/mL(Nucleic Acid Extraction-Purification Kit )
    Spec. 24T/48T/96T
  • Novel Coronavirus (2019-nCoV) Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing)

    BRIEF

    COVID-19 is an infectious disease caused by a newly discovered coronavirus named SARS-CoV2. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Elder people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. Sansure COVID-19 diagnostic solutions are used to directly detect  the presence of viral RNA, which will be detectable in patients before antibodies form or symptoms of the disease are present, which means the test results can tell whether or not that someone gets virus very early on in their illness.

    PERFORMANCE

    • One-tube/fast release technology
    • Up to 96 samples at one time
    • Simple operation process, less specialist training
    • Room temperature lysis, less contamination
    • Sampling types : nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, sputum, serum, whole blood ,Feces
    • Enhance large-scale screening efficiency
    • Internal control: human housekeeping gene RNase P

    PARAMETERS

    Product features Parameters
    Specimen Type nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, sputum, serum, whole blood, feces
    Extraction Platform One-tube fast release technology / Advanced magnetic beads technology
    Internal Control Rnase P gene
    PCR Instrument SLAN-96P, ABI7500, QuantStudio 5 , Roche 480, MA-6000, Portable Molecule Workstation ( S-Q31A )
    Sensitivity 200copies/mL
    Spec. 24T/48T